Page last updated: 2024-09-03

nitrobenzylthioinosine 5'-monophosphate and Leishmaniasis

nitrobenzylthioinosine 5'-monophosphate has been researched along with Leishmaniasis in 1 studies

*Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL). [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoki, JI; Cotrim, PC; Ramos, DC; Yamashiro-Kanashiro, EH1

Other Studies

1 other study(ies) available for nitrobenzylthioinosine 5'-monophosphate and Leishmaniasis

ArticleYear
Efficacy of the tubercidin antileishmania action associated with an inhibitor of the nucleoside transport.
    Parasitology research, 2009, Volume: 104, Issue:2

    Topics: Animals; Antiparasitic Agents; Cells, Cultured; Drug Therapy, Combination; Enzyme Inhibitors; Leishmania; Leishmaniasis; Macrophages; Mice; Mice, Inbred BALB C; Schistosoma mansoni; Thioinosine; Thionucleotides; Trypanosoma brucei gambiense; Tubercidin

2009